0317 (0317) Fair Value & Analysis

Industrials · Market cap HK$16.9B

0 0317 0317 · HK

PriceHK$11.95

Fair ValueHK$30.17

Upside+152.5%

Quality42/100

Evidence: Medium Range HK$24.41 – HK$39.12

Fair value as of: Jul 1, 2026

From 17 valuation models · updated today

Share price −16.7% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$11.90 – HK$17.51 · fair‑value band HK$24.41 – HK$39.12 · the HK$11.95 price screens below the HK$30.17 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0317 (0317) currently trades at HK$11.95, while our model-based Fair Value estimate is HK$30.17 — implying the stock looks roughly 152.5% undervalued today. We read business quality at 42/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 0317 generated revenue of HK$22.6B at a net margin of 5.4%. Revenue grew 56.1% year over year. It earns a return on equity of 6.6%. The balance sheet holds a net cash position of HK$1.4B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$22.6B

Revenue growth (YoY) +56.1%

Net margin 5.4%

Return on equity 6.6%

Free cash flow −HK$354M FY2025

P/E ratio 12.0

More key figures

Operating margin 2.0%

EPS (TTM) HK$0.9424

Dividend yield 1.8%

EPS growth (YoY) +115%

Net cash HK$1.4B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0317 reported revenue of HK$20.0B in FY2025 versus HK$11.7B in FY2021, a compound +14.4%/yr. Reported net income was HK$982M in FY2025, compounding +87.5%/yr from FY2021.

Revenue +14.4%/yr

FY21 HK$11.7B

FY22 HK$12.8B

FY23 HK$16.1B

FY24 HK$19.4B

FY25 HK$20.0B

Net income +87.5%/yr

FY21 HK$79.4M

FY22 HK$688M

FY23 HK$48.1M

FY24 HK$377M

FY25 HK$982M

Is 0317 fairly valued? → Check now

Similar stocks

6 more Aerospace & Defense stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
General Electric Company GE	C$46.59	C$22.78	-51%
RTX Corporation RYTT34	R$155.45	R$83.92	-46%
The Boeing Company BCO	€198.20	€51.07	-74%
Airbus SE EADSF	$217.43	$138.69	-36%
Safran SA SAFRY	$94.54	$57.23	-39%
Rolls-Royce Holdings RYCEY	$18.79	$9.46	-50%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0317 (0317) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$30.17 versus a price of HK$11.95 — about +152% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0317?

Our model-based fair value for 0317 is HK$30.17 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$11.95.

What is the quality score of 0317?

0317 has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0317 (0317)?

0317 reported trailing-twelve-month revenue of about HK$22.6B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0317?

The net profit margin of 0317 is about 5.4%, meaning it keeps roughly 5.4% of revenue as net income. Based on the latest reported figures.

Does 0317 pay a dividend?

0317 currently shows a dividend yield of about 1.78% relative to its recent price (as of Jul 1, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.